273 related articles for article (PubMed ID: 36637615)
21. Cancer stem cells in pediatric brain tumors.
Lasky JL; Choe M; Nakano I
Curr Stem Cell Res Ther; 2009 Dec; 4(4):298-305. PubMed ID: 19500067
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cells in nervous system tumors.
Singh SK; Clarke ID; Hide T; Dirks PB
Oncogene; 2004 Sep; 23(43):7267-73. PubMed ID: 15378086
[TBL] [Abstract][Full Text] [Related]
23. The SVZ and Its Relationship to Stem Cell Based Neuro-oncogenesis.
Kusne Y; Sanai N
Adv Exp Med Biol; 2015; 853():23-32. PubMed ID: 25895705
[TBL] [Abstract][Full Text] [Related]
24. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
25. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
[TBL] [Abstract][Full Text] [Related]
26. Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model.
Lee G; Auffinger B; Guo D; Hasan T; Deheeger M; Tobias AL; Kim JY; Atashi F; Zhang L; Lesniak MS; James CD; Ahmed AU
Mol Cancer Ther; 2016 Dec; 15(12):3064-3076. PubMed ID: 27765847
[TBL] [Abstract][Full Text] [Related]
27. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
28. Mouse induced glioma-initiating cell models and therapeutic targets.
Kondo T
Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
[TBL] [Abstract][Full Text] [Related]
29. Glioma stem cells: a midterm exam.
Stiles CD; Rowitch DH
Neuron; 2008 Jun; 58(6):832-46. PubMed ID: 18579075
[TBL] [Abstract][Full Text] [Related]
30. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
31. CD133 expression and MYCN amplification induce chemoresistance and reduce average survival time in pediatric neuroblastoma.
Zhong ZY; Shi BJ; Zhou H; Wang WB
J Int Med Res; 2018 Mar; 46(3):1209-1220. PubMed ID: 29322842
[TBL] [Abstract][Full Text] [Related]
32. Advances on Epigenetic Drugs for Pediatric Brain Tumors.
Skouras P; Markouli M; Strepkos D; Piperi C
Curr Neuropharmacol; 2023; 21(7):1519-1535. PubMed ID: 36154607
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem cells and the biology of brain tumors.
Flores DG; Ledur PF; Abujamra AL; Brunetto AL; Schwartsmann G; Lenz G; Roesler R
Curr Stem Cell Res Ther; 2009 Dec; 4(4):306-13. PubMed ID: 19804368
[TBL] [Abstract][Full Text] [Related]
34. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of glioma stem cells.
Sampetrean O; Saya H
Brain Tumor Pathol; 2013 Oct; 30(4):209-14. PubMed ID: 23584571
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
Gopisetty G; Xu J; Sampath D; Colman H; Puduvalli VK
Oncogene; 2013 Jun; 32(26):3119-29. PubMed ID: 22945648
[TBL] [Abstract][Full Text] [Related]
38. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.
Guessous F; Zhang Y; Kofman A; Catania A; Li Y; Schiff D; Purow B; Abounader R
Cell Cycle; 2010 Mar; 9(6):1031-6. PubMed ID: 20190569
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
40. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells.
Xia H; Cheung WKC; Ng SS; Jiang X; Jiang S; Sze J; Leung GKK; Lu G; Chan DTM; Bian XW; Kung HF; Poon WS; Lin MC
J Biol Chem; 2012 Mar; 287(13):9962-9971. PubMed ID: 22253443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
